HC Wainwright & Co. initiated coverage on Edesa Biotech with a new price target
$EDSA
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. initiated coverage of Edesa Biotech with a rating of Buy and set a new price target of $16.00